Echocardiografhic changes in dogs long term treated with doxorubicin
| Autor: | Aparecido Antonio Camacho, C.E.V. Silva |
|---|---|
| Přispěvatelé: | Universidade Estadual Paulista (Unesp) |
| Jazyk: | portugalština |
| Rok vydání: | 2005 |
| Předmět: |
medicine.medical_specialty
Doxorrubicina medicine.medical_treatment Diastole cardiotoxicity Mitral valve Internal medicine Dog Medicine echocardiography Interventricular septum Systole Saline cardiotoxicidade Cão General Veterinary Cumulative dose business.industry Dilated cardiomyopathy medicine.disease medicine.anatomical_structure Ventricle Doxorubicin Cardiology business Ecocardiografia |
| Zdroj: | SciELO Repositório Institucional da UNESP Universidade Estadual Paulista (UNESP) instacron:UNESP |
| ISSN: | 0102-0935 |
| Popis: | Submitted by Guilherme Lemeszenski (guilherme@nead.unesp.br) on 2013-08-22T18:55:40Z No. of bitstreams: 1 S0102-09352005000300004.pdf: 216486 bytes, checksum: 54bc29d20f8d697a4965a323e9fa0047 (MD5) Made available in DSpace on 2013-08-22T18:55:40Z (GMT). No. of bitstreams: 1 S0102-09352005000300004.pdf: 216486 bytes, checksum: 54bc29d20f8d697a4965a323e9fa0047 (MD5) Previous issue date: 2005-06-01 Made available in DSpace on 2013-09-30T17:52:23Z (GMT). No. of bitstreams: 2 S0102-09352005000300004.pdf: 216486 bytes, checksum: 54bc29d20f8d697a4965a323e9fa0047 (MD5) S0102-09352005000300004.pdf.txt: 26433 bytes, checksum: e49de286fd093694ddf461a961dda078 (MD5) Previous issue date: 2005-06-01 Submitted by Vitor Silverio Rodrigues (vitorsrodrigues@reitoria.unesp.br) on 2014-05-20T13:14:18Z No. of bitstreams: 2 S0102-09352005000300004.pdf: 216486 bytes, checksum: 54bc29d20f8d697a4965a323e9fa0047 (MD5) S0102-09352005000300004.pdf.txt: 26433 bytes, checksum: e49de286fd093694ddf461a961dda078 (MD5) Made available in DSpace on 2014-05-20T13:14:18Z (GMT). No. of bitstreams: 2 S0102-09352005000300004.pdf: 216486 bytes, checksum: 54bc29d20f8d697a4965a323e9fa0047 (MD5) S0102-09352005000300004.pdf.txt: 26433 bytes, checksum: e49de286fd093694ddf461a961dda078 (MD5) Previous issue date: 2005-06-01 Avaliou-se a cardiotoxicidade da doxorrubicina utilizando-se sete cães adultos, clinicamente normais, que receberam 30mg/m² de cloridrato de doxorrubicina (Adriblastina®) por via intravenosa, a cada 21 dias, durante 168 dias (grupo A), perfazendo dose cumulativa total de 240mg/m². em outros sete cães (grupo B) administraram-se 5ml de solução salina 0,9% estéril por via intravenosa, seguindo-se o esquema de aplicação proposto anteriormente. Os animais foram avaliados, periodicamente, por meio de exames ecocardiográficos em modo-M e bidimensional. Verificou-se aumento (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|